Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.238NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.217NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.527NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.121NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.115NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21367.3US
AY.127.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.422NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20237.1US
B.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used